NCT00650598 - A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction | Biotech Hunter

Enrollment

328

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Pain, Postoperative

Interventions

DRUG

valdecoxib

valdecoxib 40 mg (two 20-mg tablets) loading dose by mouth on Day 1 followed by 20 mg twice daily (BID) on Days 2-6

DRUG

diclofenac

diclofenac sodium delayed release tablets 75 mg by mouth twice daily (BID) for 6 days

Trial Locations (25)

10330

Pfizer Investigational Site, Bangkok

10400

Pfizer Investigational Site, Bangkok

10700

Pfizer Investigational Site, Bangkok

50586

Pfizer Investigational Site, Kuala Lumpur

56000

Pfizer Investigational Site, Cheras

59100

Pfizer Investigational Site, Kuala Lumpur

529889

Pfizer Investigational Site, Singapore

SA 5000

Pfizer Investigational Site, Adelaide

Unknown

Pfizer Investigational Site, Hong Kong

Pfizer Investigational Site, Shatin, New Territories

Pfizer Investigational Site, Auckland

Pfizer Investigational Site, Christchurch

Pfizer Investigational Site, Wellington

Pfizer Investigational Site, Manila

Pfizer Investigational Site, Quezon

Pfizer Investigational Site, Quezon City

Pfizer Investigational Site, Seoul

Pfizer Investigational Site, Kaohsiung City

Pfizer Investigational Site, Keelung

Pfizer Investigational Site, Taipei

Pfizer Investigational Site, Bangkok

Pfizer Investigational Site

110-744

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

140-757

Pfizer Investigational Site, Seoul